Chronic venous insufficiency: Angiogenesis

Phlebolymphology

Volumn , Issue 32, 2001, Pages 13-19

  Coleridge Smith, P D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALPHA 2 MACROGLOBULIN; ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 13A; CELL ADHESION MOLECULE; COLLAGEN TYPE 4; CYTOKINE; DAFLON; DIOSMIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; GROWTH PROMOTOR; HEMOSIDERIN; HESPERIDIN; L SELECTIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN;

ANGIOGENESIS; CAPILLARY PROLIFERATION; CHRONIC VEIN INSUFFICIENCY; COMPRESSION THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; IMMUNOHISTOCHEMISTRY; REVIEW; SKIN;

EID: 0034921178     PISSN: 12860107     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Pericapillary fibrin in the ulcer-bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration
2. Local microcirculation in chronic venous incompetence and leg ulcers
3. Microcirculatory disturbances - The final cause for venous leg ulcers?
4. Microangiopathy in severe chronic venous insufficiency evaluated by fluorescence video-microscopy
5. Lymphatic microangiopathy: A complication of severe chronic venous incompetence (CVI)
6. Microangiopathy due to chronic venous incompetence evaluated by fluorescein videomicroscopy
7. Changes in endothelial cell mass, luminal volume and capillary number in the gravitational syndrome
8. Angiogenesis: New insights and therapeutic potential
9. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
10. Vascular endothdial growth factor is a secreted angiogenic mitogen
11. Vascular permeability factor (VPF, VEGF) in tumor biology
12. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes
13. Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency
14. Endothelial activation response to oral micronised flavonoid therapy in patients with chronic venous disease - A prospective study
15. Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: A pilot study
16. Complete inhibition of angiogenesis and growth of microtumors by antivascular endothelial growth factor neutralizing antibody: Novel concepts of angiostatic therapy from intravital video-microscopy
17. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents
18. Patterns of epidermal growth factor receptor, basic fibroblast growth factor and transforming growth factor-beta3 expression in skin with chronic venous insufficiency
19. Growth factors, tissue and urokinase-type plasminogen activators in venous ulcers
20. Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-betal gene expression and protein production
21. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration
22. The "trap" hypothesis of venous ulceration
23. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula
24. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers
25. Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers